|
Advocacy and Policy Development
WHO continued advocacy for
evidence based strategy of ‘skilled attendance at birth’ contributed to
identification of skilled birth attendance both at institution and community
as one of the key strategies of RCH-II.
To empower the peripheral
health functionaries, especially ANMs,
certain life saving skills and use of drugs as emergency obstetric first aid
has been permitted by ANMs.
E.g. Use of tablet misoprotol
for prevention of PPH and Injection oxytocin
for treatment of PPH, Injection Magnesium Sulphate for treatment of Eclampsia.
WHO was identified as lead
Development Partner under RCH-2 to support the development of technical
guidelines especially on Skilled Attendance at birth and Emergency Obstetrics
Care under RCH-II.
Extensive contributions were made by the technical team at UNFPA, India through
out the process. In addition, this exercise was further facilitated and
support by White Ribbon Alliance of India.
Another significant
contribution was the introduction of maternal death reviews which were
envisaged as a tool for in depth analysis in the factors (avoidable/
remediable) responsible for maternal mortality.
Through a multi site
demonstration of use of safe techniques for abortion (Manual Vacuum
Aspiration, MVA) at Primary Health Centres,
WHO assisted the government with the expansion of safe abortion services at
PHC and mainstreaming the same in RCH-2.
Technical assistance was provided in carrying the amendments in the MTP
Act.
|
